Expansion momentum Seegnal is actively expanding into the United States with pilots and office expansions, signaling growing market appetite and a willingness to adopt prescription safety AI at scale in the world’s largest healthcare market.

Regulatory & quality recognition Gold Mark award from the Standards Institution of Israel and related certifications enhance credibility for healthcare buyers prioritizing compliance, risk reduction, and standards-aligned solutions.

Integrated care impact The AI-enhanced Prescription Operating System embeds in clinical workflows to reduce medication errors and costs in real time, offering a compelling value proposition for hospitals aiming to lower total cost of care.

Financial viability Current revenue is in the low-to-mid single-digit millions with a practical path to scale through national deployments and multi-site adoption, indicating a viable ROI case for enterprise healthcare systems.

Leadership and vision Recent leadership changes and ongoing growth signals, including CEO appointment and rapid deployment across geographies, present a narrative of strategic momentum that can be leveraged to engage enterprise buyers seeking innovative governance of prescribing practices.